| |
| |
|
| Insider
Information: |
Mclaughlin Kevin F |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
11,900 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$587,979 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
11,900 |
|
|
| Total
Value |
$587,979 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acceleron Pharma Inc |
XLRN |
SVP, CFO and Treasurer |
2021-11-19 |
0 |
2014-05-19 |
0 |
Premium* |
|
|
Vericel Corp |
VCEL |
|
2024-05-01 |
11,900 |
2020-04-29 |
0 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-06-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2016-05-23 |
4 |
OE |
$5.28 |
$1,584 |
D/D |
300 |
92,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
AS |
$125.12 |
$62,560 |
D/D |
(500) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-10 |
4 |
OE |
$27.97 |
$16,792 |
D/D |
500 |
11,716 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-04 |
4 |
D |
$124.31 |
$77,569 |
D/D |
(624) |
10,592 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2019-04-02 |
4 |
AS |
$48.02 |
$31,117 |
D/D |
(648) |
42,279 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-05 |
4 |
AS |
$120.43 |
$181,982 |
D/D |
(1,499) |
5,813 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2017-01-04 |
4 |
AS |
$26.87 |
$46,667 |
D/D |
(1,700) |
70,900 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2020-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
1,750 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2021-04-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,750 |
3,500 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-01-12 |
4 |
OE |
$3.88 |
$7,760 |
D/D |
2,000 |
27,000 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2015-01-12 |
4 |
AS |
$40.38 |
$81,318 |
D/D |
(2,000) |
25,000 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
– • – |
2022-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
6,100 |
0 |
- |
|
| VCEL |
Vericel Corp |
|
• • – |
2023-04-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
8,700 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-11 |
4 |
OE |
$41.20 |
$127,720 |
D/D |
3,100 |
14,316 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-11 |
4 |
AS |
$125.00 |
$387,500 |
D/D |
(3,100) |
11,216 |
0 |
% |
|
| VCEL |
Vericel Corp |
|
• • – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,200 |
11,900 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-04 |
4 |
AS |
$123.49 |
$406,992 |
D/D |
(3,280) |
7,312 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-09-08 |
4 |
AS |
$24.90 |
$82,170 |
D/D |
(3,300) |
0 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2014-09-08 |
4 |
OE |
$3.88 |
$12,804 |
D/D |
3,300 |
3,300 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
OE |
$27.97 |
$141,537 |
D/D |
3,872 |
15,088 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2020-12-09 |
4 |
AS |
$125.03 |
$484,116 |
D/D |
(3,872) |
11,216 |
0 |
% |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2018-01-02 |
4 |
AS |
$42.42 |
$169,680 |
D/D |
(4,000) |
45,300 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2018-04-03 |
4 |
AS |
$38.31 |
$153,792 |
D/D |
(4,000) |
43,939 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
42,927 |
0 |
- |
|
| XLRN |
Acceleron Pharma Inc |
SVP, CFO and Treasurer |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
4,868 |
10,681 |
0 |
- |
|
101 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
